Table 2 Clinical characteristics in the MCCD cohort
From: Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes
|  | Patients (n = 352) | Patients with information (%) |
|---|---|---|
Multivessel stenosis (%) | 236 (67.1) | 352 (100) |
Median number of significant lesions (IQR) | 2 (1–4) | 352 (100) |
Severity of atherosclerosis | Â | 352 (100) |
 0–1 (%) | 116 (33.0) |  |
 2 (%) | 68 (19.3) |  |
 3 (%) | 61 (17.3) |  |
  ≥ 4 (%) | 107 (30.4) |  |
Mean PRSa (SD) | 17.18 (0.10) | 352 (100) |
Men (%) | 269 (76.4) | 352 (100) |
Median age (IQR) | 71 (66–78) | 352 (100) |
European (%) | 310 (88.1) | 352 (100) |
Hypertension (%) | 328 (93.2) | 352 (100) |
 Systolic hypertension (%) | 149 (42.7) | 349 (99.1) |
 Diastolic hypertension (%) | 16 (4.6) | 349 (99.1) |
 Antihypertensive drug usage (%) | 311 (88.4) | 352 (100) |
Hyperlipidemia (%) | 333 (94.9) | 351 (99.7) |
 High LDL (%) | 146 (42.8) | 341 (96.9) |
 Hypertriglyceridemia (%) | 2 (0.5) | 347 (98.6) |
 Lipid-lowering drug usage (%) | 296 (84.1) | 352 (100) |
Poor glycemic control (%) | 48 (14.0) | 343 (97.4) |
Median BMI (IQR) | 29.82 (26.15–33.90) | 346 (98.3) |
Ex- or current smokersb (%) | 197 (56.0) | 352 (100) |
Median type 2 diabetes durationb (IQR) | 15 (8–22) | 189 (53.7) |
Median age of type 2 diabetes diagnosisb (IQR) | 58 (47–64) | 189 (53.7) |
Family history of heart diseaseb (%) | 209 (73.9) | 283 (83.4) |